Update information

Update information

February 2024: We removed the final bullet of recommendation 1.1.3.10, which said 'have a family history of TB in the past 5 years', to align it with the chapter on tuberculosis in the Green Book.

September 2019: Minor wording changes have been made to recommendation 1.7.4.2 and footnotes added to reflect new restrictions and precautions for the use of fluoroquinolone antibiotics. It is labelled [new 2016, amended 2019].

June 2019: Recommendation 1.6.1.8 has been amended to add in more detail about the meaning of contacts.

November 2018: Recommendation 1.1.3.16 on BCG vaccinations for healthcare workers and other NHS employees was updated after a surveillance review.

May 2016: Recommendation 1.2.1.1 was clarified to reflect the sequencing of tests. Reference to IGRA status was removed from recommendations 1.1.3.13; 1.1.3.16-18; 1.1.4.6; 1.1.4.8 and 1.6.1.4.

February 2016: Recommendation 1.1.3.4 has been amended to clarify that the recommendation is about assessing risk for and vaccinating the baby.

January 2016: This guideline was published. It is an update of NICE guideline CG117 (published March 2011) and replaces it. It also incorporates and adapts NICE guideline PH37 (published March 2012).

Through the scoping process we work with stakeholders to identify, prioritise and agree areas of the guideline to update. This means that areas outside the scope were not reviewed during this update and the recommendations may not reflect current practice. Areas that have not been reviewed in this update may be addressed 2 years after publication, when NICE next considers updating this guideline. NICE may undertake an update of discrete areas of the guideline if new and relevant evidence is published.

Recommendations are marked as:

  • [new 2016] if the evidence has been reviewed and the recommendation has been added or updated

  • [2016] if the evidence has been reviewed but no change has been made to the recommended action

  • [2006] if the evidence has not been reviewed since 2006

  • [2006, amended 2011] or [2011] if the evidence has not been reviewed since 2006

  • [2012] if the evidence has not been reviewed since 2012

  • [2006, amended 2011, amended 2016] or [2011, amended 2016] if the evidence has not been reviewed since 2011, but either changes have been made to the recommendation wording that change the meaning or NICE has made editorial changes to the original wording to clarify the action to be taken (see below).

  • [2006, 2012, amended 2016] or [2012, amended 2016] if the evidence has not been reviewed since 2012, but either changes have been made to the recommendation wording that change the meaning or NICE has made editorial changes to the original wording to clarify the action to be taken (see below).

Recommendations from NICE guideline CG117 that have been amended

Recommendations are labelled [2011, amended 2016] and [2006, amended 2011, amended 2016] if the evidence has not been reviewed but either:

  • changes have been made to the recommendation wording that change the meaning, or

  • NICE has made editorial changes to the original wording to clarify the action to be taken.

Further details of the specific changes to the recommendations during the 2016 update are available on request.

Recommendations from NICE guideline PH37 that have been amended

Recommendations are labelled [2012, amended 2016] if:

  • The evidence has not been reviewed, but a change has been made to clarify roles or actions in the original recommendation, extrapolate to the whole population, or where system changes such as establishment of TB control boards have been reflected

  • NICE has made editorial changes to the wording to clarify the action to be taken, but where there is no change of meaning to the original recommendation.

Further details of the specific changes to the recommendations during the 2016 update are available on request.

ISBN: 978-1-4731-5741-5

  • National Institute for Health and Care Excellence (NICE)